Form 4: OptimizeRx Director Halas Gus D Acquires Shares Through RSU Vesting

Director Halas Gus D of OptimizeRx Corp. acquired 10,061 shares of common stock on June 5, 2024, through the vesting of restricted stock units.

Summary

• On June 5, 2024, Halas Gus D, a director of OptimizeRx Corp., acquired 10,061 shares of common stock.
• The acquisition resulted from the vesting of restricted stock units (RSUs).
• The RSUs, granted on June 7, 2023, vested in full on June 5, 2024.
• Each RSU converts into one share of common stock.
• Following the transaction, Halas Gus D directly owns 80,926 shares of OptimizeRx Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to executive compensation. There is no indication of positive or negative implications for the company's performance.

Positives

• The vesting of RSUs indicates a continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates